Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 19 Mar 2026 – 20 Aug 2026, limited by LIC MF Technology Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | LIC MF Technology Fund | Nifty 500 |
|---|---|---|
| 19 Mar 2026 | ₹100.00 | ₹100.00 |
| 01 Apr 2026 | ₹100.22 | ₹98.63 |
| 14 Apr 2026 | ₹103.07 | ₹104.49 |
| 27 Apr 2026 | ₹103.49 | ₹107.52 |
| 09 May 2026 | ₹105.63 | ₹108.90 |
| 22 May 2026 | ₹106.58 | ₹106.72 |
| 04 Jun 2026 | ₹106.54 | ₹105.99 |
| 17 Jun 2026 | ₹107.65 | ₹108.88 |
| 30 Jun 2026 | ₹104.76 | ₹108.34 |
| 13 Jul 2026 | ₹109.23 | ₹109.99 |
| 25 Jul 2026 | ₹106.93 | ₹107.95 |
| 07 Aug 2026 | ₹113.68 | ₹111.71 |
| 20 Aug 2026 | ₹114.09 | ₹110.78 |
| Metric | LIC · Direct NAV ₹11.42 Very High risk Unrated | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| — | +7.23% | |
| — | +16.94% | |
| — | +14.70% | |
| — | +15.10% | |
| +14.09% | +14.07% | |
| +34.99% | — | |
| — | +17.59% | |
| — | +16.29% | |
| — | +16.00% | |
| Risk | ||
| 12.92% | 15.69% | |
| — | 0.52 | |
| — | 0.73 | |
| -4.95% | -23.08% | |
| Nifty 500 | — | |
| — | +4.66% | |
| — | 0.96 | |
| — | 109.1% | |
| — | 91.0% | |
| 1.07% | 1.14% | |
| ₹83.56Cr | ₹1,161Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹200 | — | |
| ₹1.00K | — | |
| — | 45% | |
| Karan Doshi | — | |
| 19 Mar 2026 | — | |
| 30 | — | |
| 46.4% | — | |
| 15.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.